These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


60 related items for PubMed ID: 3037094

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
    Narumi S, Nagawa Y.
    Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of calmodulin-dependent enzymes in developing rat striatum is not affected by perturbation of dopaminergic systems.
    Polli JW, Kincaid RL, Torris J, Billingsley ML.
    Synapse; 1991 Oct; 9(2):136-43. PubMed ID: 1821485
    [Abstract] [Full Text] [Related]

  • 7. Ganglioside interactions with the dopaminergic system of rats.
    Tilson HA, Harry GJ, Nanry K, Hudson PM, Hong JS.
    J Neurosci Res; 1988 Oct; 19(1):88-93. PubMed ID: 3125345
    [Abstract] [Full Text] [Related]

  • 8. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C, Okamura H.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [Abstract] [Full Text] [Related]

  • 9. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME, Hewlett GH, Pimputkar G.
    Brain Res; 1996 Sep 23; 734(1-2):35-42. PubMed ID: 8896805
    [Abstract] [Full Text] [Related]

  • 10. Acute administration of haloperidol enhances dopaminergic transmission.
    Lidsky TI, Banerjee SP.
    J Pharmacol Exp Ther; 1993 Jun 23; 265(3):1193-8. PubMed ID: 8389855
    [Abstract] [Full Text] [Related]

  • 11. Alterations in calmodulin content of rat brain areas after chronic application of haloperidol and amphetamine.
    Popov N, Schulzeck S, Nüss D, Vopel AU, Jendrny C, Struy H, Matthies H.
    Biomed Biochim Acta; 1988 Jun 23; 47(4-5):435-41. PubMed ID: 3240294
    [Abstract] [Full Text] [Related]

  • 12. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG, Bennett JP.
    Exp Neurol; 1994 Sep 23; 129(1):57-63. PubMed ID: 7925842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repeated haloperidol increases both calmodulin and a calmodulin-binding protein in rat striatum.
    Gnegy ME, Agrawal A, Hewlett K, Yeung E, Yee S.
    Brain Res Mol Brain Res; 1994 Dec 23; 27(2):195-204. PubMed ID: 7898303
    [Abstract] [Full Text] [Related]

  • 16. Relationship of calmodulin and dopaminergic activity in the striatum.
    Gnegy ME.
    Fed Proc; 1982 May 23; 41(7):2273-7. PubMed ID: 6122610
    [Abstract] [Full Text] [Related]

  • 17. Amphetamine anorexia: the effect of radio-frequency lesions and 6-OHDA injections into dopaminergic nigro-striatal bundle in cats.
    Konopacki J.
    Pol J Pharmacol Pharm; 1983 May 23; 35(6):497-502. PubMed ID: 6429650
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions.
    Spindel ER, Pettibone DJ, Wurtman RJ.
    Brain Res; 1981 Jul 20; 216(2):323-31. PubMed ID: 6265032
    [Abstract] [Full Text] [Related]

  • 20. Genotypic influences on pituitary responsiveness to haloperidol in mice.
    Morgan DG, Randall JS, Telford NA, Gordon MN, Sinha YN, Finch CE, Randall PK.
    Psychoneuroendocrinology; 1987 Jul 20; 12(3):211-8. PubMed ID: 3615750
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.